UBS iTraxx Xover Risk Reversal Pitched

© 2025 GlobalCapital, Derivia Intelligence Limited, company number 15235970, 4 Bouverie Street, London, EC4Y 8AX. Part of the Delinian group. All rights reserved.

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement | Event Participant Terms & Conditions

UBS iTraxx Xover Risk Reversal Pitched

UBS is advising selling a 475 receiver option (25 basis points upfront) and buying a 625 payer option (29bps upfront) on iTraxx Xover for October expiry to take advantage of the underpriced index.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request demo or Login
  • 4,000 annual insights
  • 700+ notes and long-form analyses
  • 4 capital markets databases
  • Daily newsletters across markets and asset classes
  • 2 weekly podcasts
Gift this article